Antibody therapeutics for cancer, inflammation, and pain. Abalone is shifting the paradigm for antibody development, isolating drug candidates directly by their modulating effects on integral membrane proteins. Its drug development programs address unmet needs in oncology, inflammation and pain sensation. Abalone is an early stage biotech start-up in the San Francisco Bay Area. It is partnering with leading academic labs, targeting G protein-coupled receptors (GPCRs) and ion channels.
